Your email has been successfully added to our mailing list.

×
0.00478468899521542 0.00478468899521542 0.0239234449760767 0.0191387559808613 0.0215311004784691 0.0148325358851675 0.0334928229665073 0.0263157894736843
Stock impact report

OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights

ONCOMED PHARMACEUTICALS (OMED) 
Last oncomed pharmaceuticals earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: oncomed.com/invest/index.cfm
Company Research Source: GlobeNewswire
-Company prioritizes its navicixizumab resources in platinum-resistant ovarian cancer; prepares to share data in Q4 of 2018- -Cash runway extended by an additional quarter to YE 2019- REDWOOD CITY, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced second quarter 2018 financial results and provided a corporate update. As of June 30, 2018, cash, cash equivalents, and short-term investments totaled $79.9 million. "The first half of the year has been focused on effective execution in the development of our pipeline of oncology candidates, including navicixizumab, etigilimab (anti-TIGIT) and GITRL-Fc which are being investigated in ongoing clinical trials,” said John Lewicki, Ph.D., President and Chief Executive Officer of OncoMed. “These activities will culminate in important data announcements later this year. We are pa Show less Read more
Impact Snapshot
Event Time:
OMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for OMED alerts
Opt-in for
OMED alerts

from News Quantified
Opt-in for
OMED alerts

from News Quantified